Clamelle of Actavis awarded in the UK

At the annual SMaRT Awards last week in Birmingham, UK, Actavis were triumphant, winning Best POM to P Switch of the Year Award for Clamelle. The Clamelle training materials were also awarded Highly Commended in the Best Educational Initiative for Pharmacists category. The SmaRT (Sales, Marketing and Retail Training) Awards, sponsored ... Read More...

Icelandic economic crisis does not affect Actavis

Generic pharmaceutical company Actavis has said that its operations will not be impacted by the current financial turmoil in Iceland. Actavis has released a statement in light of recent market events in the Icelandic financial sector. ”Actavis is not exposed to the Icelandic banks in regards to funding or normal banking facilities. ... Read More...

Actavis receives US approval for generic breast cancer drug

Actavis' generic breast cancer drug, Epirubicin Hydrochloride Injection, has been approved for sale in the US by the Food & Drug Administration (FDA). Epirubicin Hydrochloride is now the second oncology drug from Actavis approved in the US following Irinotecan Hydrochloride which was authorised earlier this year. Epirubicin Hydrochloride Injection, the generic ... Read More...